$AMST

Amesite Inc.

CIK:0001807166|SEC Filings

Statements of Operations - USD ($)	12 Months Ended
Statements of Operations - USD ($)	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Net Revenue	$ 364,777	$ 110,459
Operating Expenses
General and administrative expenses	2,510,264	2,477,888
Technology and content development	613,578	691,154
Sales and marketing	384,041	545,030
Total operating expenses	3,507,883	3,714,072
Loss from Operations	(3,143,106)	(3,603,613)
Other Income (Expense)
Interest income	47,268	77,396
Impairment expense		(90,869)
Total other income (expense), net	47,268	(13,473)
Net Loss	$ (3,095,838)	$ (3,617,086)
Earnings (Loss) per Share
Basic loss per share (in Dollars per share)	$ (0.63)	$ (1.03)
Diluted loss per share (in Dollars per share)	$ (0.63)	$ (1.03)
Weighted average shares outstanding (in Shares)	4,937,520	3,525,672

Statements of Cash Flows - USD ($)	12 Months Ended
Statements of Cash Flows - USD ($)	Jun. 30, 2026	Jun. 30, 2025
Cash Flows from Operating Activities
Net Loss	$ (3,095,838)	$ (3,617,086)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	277,406	433,803
Stock-based compensation expense	268,127	322,037
Allowance for doubtful accounts	17,277
Impairment of capitalized software		90,869
Forfeiture of accrued director compensation		(200,000)
Changes in operating assets and liabilities which used cash:
Accounts receivable	(25,662)	23,719
Prepaid expenses and other current assets	(5,349)	309,389
Accounts payable	25,080	(23,494)
Accrued compensation	395,402	209,813
Deferred revenue	80	36,745
Other accrued liabilities	(3,240)	(41,043)
Net cash and cash equivalents used in operating activities	(2,146,717)	(2,455,248)
Cash Flows from Investing Activities
Purchase of property and equipment	(5,721)
Investment in capitalized software	(225,098)	(378,300)
Net cash and cash equivalents used in investing activities	(230,819)	(378,300)
Cash Flows from Financing Activities
Proceeds from the sale of common stock	2,342,927	3,095,950
Net cash and cash equivalents provided by financing activities	2,342,927	3,095,950
Net increase (decrease) in cash, cash equivalents, and restricted cash	(34,609)	262,402
Cash, cash equivalents, and restricted cash - Beginning of year	2,433,418	2,171,016
Cash, cash equivalents, and restricted cash - End of year	2,398,809	2,433,418
RECONCILIATION OF CASH, CASH EQUIVALENTS, AND RESTRICTED CASH TO THE BALANCE SHEET:
Cash and cash equivalents	2,298,809	2,333,418
Restricted cash, non-current	100,000	100,000
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	2,398,809	2,433,418
SUPPLEMENTAL SCHEDULE OF NON-CASH FINANCING ACTIVITIES:
Settle restricted stock units through common stock issuance to directors	400,000	399,975
Issuance of common stock for accrued director compensation		21,890
Issuance of common stock for public offering consulting expenses		$ 655,000

Balance Sheets - USD ($)	Jun. 30, 2026	Jun. 30, 2025
Current Assets
Cash and cash equivalents	$ 2,298,809	$ 2,333,418
Accounts receivable, net of allowance for uncollectible accounts of $17,277 and $0 at June 30, 2026 and 2025, respectively	14,726	6,341
Prepaid expenses and other current assets	99,449	94,100
Total current assets	2,412,984	2,433,859
Noncurrent Assets
Restricted cash	100,000	100,000
Property and equipment, net of accumulated depreciation of $168,445 and $142,907 at June 30, 2026 and 2025, respectively	19,619	39,436
Capitalized software, net of accumulated amortization of $4,009,186 and $3,757,318 at June 30, 2026 and 2025, respectively	497,034	523,804
Total noncurrent assets	616,653	663,240
Total assets	3,029,637	3,097,099
Current Liabilities
Accounts payable	50,493	25,413
Accrued compensation	238,600	243,198
Deferred revenue	36,825	36,745
Other accrued liabilities	50,000	53,240
Total current liabilities	375,918	358,596
Stockholders' Equity
Common stock, $.0001 par value; 100,000,000 shares authorized; 6,549,851 and 4,572,713 shares issued and outstanding at June 30, 2026 and 2025, respectively	655	458
Preferred stock, $.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding at June 30, 2026 and 2025, respectively
Additional paid-in capital	47,199,489	44,188,632
Accumulated deficit	(44,546,425)	(41,450,587)
Total stockholders' equity	2,653,719	2,738,503
Total liabilities and stockholders' equity	$ 3,029,637	$ 3,097,099